Health infrastructure in Côte d’Ivoire remains weak and unevenly distributed as a result of insufficient investment and the damage borne throughout a decade of conflict. This has had a negative impact on access to health services, making it difficult for health care agents to adequately satisfy the population’s needs. Boosting investment in...
What are some of the challenges facing the universal health care system in Côte d’Ivoire?
Côte d’Ivoire is a member of the West African Pharmaceutical Manufacturers Association (WAPMA), comprising ECOWAS and EMOA member states that total 15 countries and a population of about 340m people. The country stands with Senegal today at the forefront of pharmaceuticals production in the French-speaking West African world, while Ghana and...
Côte d’Ivoire is setting the health sector back on its feet after a decade of armed conflict and political division. As the 2012-15 National Health Development Plan reached its closing period, progress seemed clear and the country was geared towards rebuilding and constructing health infrastructure and facilities, training and hiring personnel, setting new standards and, ultimately, working to...
Cote d’Ivoire has seen rapid growth since a decade-long bout of civil unrest ended in 2011. The largest economy in UEMOA, and the third largest in ECOWAS, the country accounts for more than 30% of the eight-member bloc’s GDP.
Rising consumer demand and an increased role for the private sector look set to drive expansion and open new doors for investors in Saudi Arabia’s health care industry.
Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.
Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.
Register Here×